Anti-HDAC3 antibody [Y415] (ab32369)

ab32369 has been referenced in 19 publications.

• Xu G  et al. Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5. Int J Mol Med 41:155-163 (2018). PubMed: 29115379
• Yano M  et al. Association of histone deacetylase expression with histology and prognosis of ovarian cancer. Oncol Lett 15:3524-3531 (2018). PubMed: 29456726
• Chaiyawat P  et al. Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications. Mod Pathol 31:264-274 (2018). IHC-P ; Human . PubMed: 28984297
• Dong S  et al. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor. Oncotarget 8:40583-40593 (2017). PubMed: 28489564
• Meng ZZ  et al. The pro-inflammatory signalling regulator Stat4 promotes vasculogenesis of great vessels derived from endothelial precursors. Nat Commun 8:14640 (2017). PubMed: 28256502
• Lai Q  et al. H3K9ac and HDAC2 Activity Are Involved in the Expression of Monocarboxylate Transporter 1 in Oligodendrocyte. Front Mol Neurosci 10:376 (2017). PubMed: 29184483
• Bao M  et al. 3D microniches reveal the importance of cell size and shape. Nat Commun 8:1962 (2017). PubMed: 29213086
• Sun XY  et al. Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3. Oncotarget 8:75232-75242 (2017). PubMed: 29088860
• Huang R  et al. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer. Oncotarget 7:4695-711 (2016). WB, IHC-P ; Human . PubMed: 26683361
• Romani B  et al. HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages. J Biol Chem 291:2696-711 (2016). WB, IP ; Human . PubMed: 26679995
• Romani B  et al. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin. Sci Rep 6:31924 (2016). PubMed: 27550312
• de Graaff MA  et al. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation. Lab Invest 96:885-94 (2016). PubMed: 27270875
• Liu X  et al. Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5?2 signaling pathway. Cancer Sci 106:857-66 (2015). IHC-P ; Human . PubMed: 25940092
• Jamaladdin S  et al. Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells. Proc Natl Acad Sci U S A 111:9840-5 (2014). Mouse . PubMed: 24958871
• Chuang MJ  et al. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. PLoS One 8:e73401 (2013). WB ; Human . PubMed: 24023871
• Papadopoulos P  et al. A dual reporter mouse model of the human ß-globin locus: applications and limitations. PLoS One 7:e51272 (2012). WB ; Mouse . PubMed: 23272095
• Funato H, Oda S, Yokofujita J, Igarashi H, Kuroda Fasting and high-fat diet alter histone deacetylase expression in the medial hypothalamus. PLoS One 6:e18950 (2011). IHC-FoFr ; Mouse . PubMed: 21526203
• Stojsic Z  et al. Large-cell neuroendocrine carcinoma of the ampulla of Vater. Med Oncol 27:1144-8 (2010). PubMed: 19898974
• Knutson SK  et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J 27:1017-28 (2008). IHC-P ; Mouse . PubMed: 18354499